Viewing Study NCT00284804


Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2025-12-25 @ 5:31 PM
Study NCT ID: NCT00284804
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2006-01-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module